Second cancer risk following testicular cancer: a follow-up study of 1,909 patients

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
F E van LeeuwenR Somers

Abstract

Improved survival in testicular cancer has been accompanied by concern about long-term side effects of therapy. We assessed the evolution of second cancer (SC) risk over a prolonged follow-up period, which has been rarely studied in large patient series. We estimated the risk of SCs in 1,909 patients with testicular cancer diagnosed in the Netherlands from 1971 to 1985. Complete medical information was obtained up to at least January 1988 for 92% of patients. Median follow-up was 7.7 years. For 89% of second tumors the diagnosis was confirmed through review of histologic slides; for an additional 8%, the diagnosis was verified by pathology reports only. Seventy-eight patients developed a SC 1 year or more after start of treatment, as compared with 47.6 expected on the basis of incidence rates in the general population (relative risk [RR], 1.6; 95% confidence interval [CI], 1.3 to 2.1). The mean 15-year actuarial risk of all SCs was 9.8% (95% CI, 7.5% to 12.8%). Significantly increased RRs were observed for all gastrointestinal cancers combined (RR, 2.6; 95% CI, 1.7 to 3.9), stomach cancer (RR, 3.7; 95% CI, 1.8 to 6.8), contralateral testicular cancer (CLTC) (RR, 35.7; 95% CI, 21.8 to 55.2), and leukemia (RR, 5.1; 95% CI, 1.4 to...Continue Reading

Citations

Sep 1, 1994·British Journal of Haematology·L T VlasveldB Löwenberg
Apr 1, 1996·Annals of Medicine·K Hoekman, J B Vermorken
Jul 24, 1997·The New England Journal of Medicine·G J Bosl, R J Motzer
Nov 14, 1997·International Journal of Urology : Official Journal of the Japanese Urological Association·S SaikiT Kotake
Dec 10, 1999·Seminars in Surgical Oncology·C KollmannsbergerC Bokemeyer
Jun 1, 2000·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·S Culine, J P Droz
Jan 17, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alan Horwich
Jan 1, 2005·Journal of Cancer Research and Clinical Oncology·J WiereckyC Bokemeyer
Jan 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alexandra W van den Belt-DuseboutFlora E van Leeuwen
Apr 4, 2007·International Journal of Occupational Medicine and Environmental Health·Hermann C RoemerKlaus Golka
Dec 12, 2007·International Journal of Clinical Oncology·Kosuke MizutaniYoshinobu Hirose
Oct 2, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alexandra W van den Belt-DuseboutFlora E van Leeuwen
Jan 6, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Torgrim TandstadGabriella Cohn-Cedermark
Mar 16, 2011·Nature Reviews. Urology·Chunkit Fung, David J Vaughn
Jan 31, 2013·Korean journal of urology·Yu Seob Shin, Hyung Jin Kim
Jan 19, 2018·International Journal of Urology : Official Journal of the Japanese Urological Association·Tomoya Fukawa, Hiro-Omi Kanayama
Jul 11, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Harmke J GrootMichael Schaapveld
Dec 1, 1993·Australian and New Zealand Journal of Medicine·E SegelovH Kronenberg
Dec 22, 1999·International Journal of Cancer. Journal International Du Cancer·C KollmannsbergerC Bokemeyer
Jun 1, 1997·Annals of Surgical Oncology·J P van BastenH Schraffordt Koops
May 14, 1998·The British Journal of Radiology·C LambertC R Freeman
Sep 22, 2005·Journal of the National Cancer Institute·Lois B TravisEthel S Gilbert
Feb 28, 2006·International Urology and Nephrology·Nathan LawrentschukDamien M Bolton
Mar 2, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Derek Raghavan
Jun 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Timothy GilliganPhilip W Kantoff
Nov 11, 2006·International Journal of Cancer. Journal International Du Cancer·Lorenzo RichiardiPaul Brennan
Oct 22, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Xavier Garcia-del-MuroJosep R Germá-Lluch
Jun 1, 2011·International Journal of Cancer. Journal International Du Cancer·Kristine E AndreassenSophie D Fosså
Oct 8, 2013·International Urology and Nephrology·D OndrusL Friedova
Jul 16, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nasser Hanna, Lawrence H Einhorn
Sep 18, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Chunkit FungLois B Travis
Mar 10, 2018·International Braz J Urol : Official Journal of the Brazilian Society of Urology·Aditya JainTimur Mitin
Feb 15, 2001·Pathology Oncology Research : POR·Z OroszJ Szántó
Apr 17, 1999·Journal of Pediatric Hematology/oncology·G A HaleM M Hudson
Aug 12, 1999·BJU International·G M Mead
May 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Pablo M BedanoLawrence H Einhorn
Jun 12, 2009·World Journal of Urology·Nathan Lawrentschuk, Neil Fleshner
Aug 20, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Karen E HoffmanAnthony V D'Amico
Oct 17, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sigmund BrabrandGustav Lehne
Oct 13, 2012·British Journal of Cancer·M SchaapveldF E van Leeuwen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.